Unanswered questions in the management of axial spondyloarthritis: an opinion piece

Xenofon Baraliakos; Atul Deodhar

doi:10.1007/s10067-014-2740-x

Unanswered questions in the management of axial spondyloarthritis: an opinion piece

Xenofon Baraliakos, Atul Deodhar

Arthritis & Rheumatic Diseases

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1359-1365
Number of pages	7
Journal	Clinical Rheumatology
Volume	33
Issue number	10
DOIs	https://doi.org/10.1007/s10067-014-2740-x
State	Published - Oct 1 2014

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s10067-014-2740-x

Cite this

@article{b7b4b6a534c249cb9f1dc7ae812a6e7b,

title = "Unanswered questions in the management of axial spondyloarthritis: an opinion piece",

author = "Xenofon Baraliakos and Atul Deodhar",

note = "Funding Information: Acknowledgments The authors would like to thank Barry Weichman for assistance in drafting the manuscript and Andrew Horgan of BioScience Communications, Inc, New York, NY, for editorial assistance, activities that were supported by Novartis Pharmaceuticals. This work was supported by an unrestricted writing grant from Novartis Pharmaceuticals. No compensation was paid to the authors.",

year = "2014",

month = oct,

day = "1",

doi = "10.1007/s10067-014-2740-x",

language = "English (US)",

volume = "33",

pages = "1359--1365",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "10",

}

TY - JOUR

T1 - Unanswered questions in the management of axial spondyloarthritis

T2 - an opinion piece

AU - Baraliakos, Xenofon

AU - Deodhar, Atul

N1 - Funding Information: Acknowledgments The authors would like to thank Barry Weichman for assistance in drafting the manuscript and Andrew Horgan of BioScience Communications, Inc, New York, NY, for editorial assistance, activities that were supported by Novartis Pharmaceuticals. This work was supported by an unrestricted writing grant from Novartis Pharmaceuticals. No compensation was paid to the authors.

PY - 2014/10/1

Y1 - 2014/10/1

UR - http://www.scopus.com/inward/record.url?scp=84957427006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957427006&partnerID=8YFLogxK

U2 - 10.1007/s10067-014-2740-x

DO - 10.1007/s10067-014-2740-x

M3 - Editorial

C2 - 24941929

AN - SCOPUS:84957427006

VL - 33

SP - 1359

EP - 1365

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 10

ER -

Unanswered questions in the management of axial spondyloarthritis: an opinion piece

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this